Robert Stoehr

11.2k total citations
135 papers, 3.9k citations indexed

About

Robert Stoehr is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Robert Stoehr has authored 135 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Surgery, 41 papers in Molecular Biology and 39 papers in Oncology. Recurrent topics in Robert Stoehr's work include Bladder and Urothelial Cancer Treatments (62 papers), Urinary and Genital Oncology Studies (53 papers) and Sarcoma Diagnosis and Treatment (14 papers). Robert Stoehr is often cited by papers focused on Bladder and Urothelial Cancer Treatments (62 papers), Urinary and Genital Oncology Studies (53 papers) and Sarcoma Diagnosis and Treatment (14 papers). Robert Stoehr collaborates with scholars based in Germany, United States and Switzerland. Robert Stoehr's co-authors include Arndt Hartmann, Ruth Knuechel, Ferdinand Hofstaedter, Abbas Agaimy, Stefan Denzinger, Arndt Hartmann, Peter J. Wild, Maximilian Burger, Christian Hafner and Bernd Wullich and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Robert Stoehr

131 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Stoehr Germany 36 1.9k 1.5k 1.1k 879 576 135 3.9k
Shaobo Zhang United States 37 1.7k 0.9× 1.6k 1.0× 511 0.5× 1.6k 1.8× 681 1.2× 100 3.7k
Fadi Brimo Canada 33 1.5k 0.8× 946 0.6× 803 0.7× 1.4k 1.6× 467 0.8× 146 3.3k
Pantaleo Bufo Italy 33 621 0.3× 1.2k 0.8× 784 0.7× 571 0.6× 522 0.9× 110 2.9k
Akiko Kunita Japan 31 997 0.5× 1.1k 0.8× 1.9k 1.7× 509 0.6× 511 0.9× 60 3.2k
Masatsugu Iwamura Japan 27 795 0.4× 773 0.5× 822 0.7× 1.3k 1.5× 348 0.6× 204 2.9k
Teiichi Motoyama Japan 40 1.3k 0.7× 3.1k 2.0× 1.1k 1.0× 935 1.1× 825 1.4× 185 5.8k
Thomas Papadopoulos Germany 25 1.1k 0.6× 539 0.4× 829 0.7× 591 0.7× 235 0.4× 58 2.4k
Annette Ramaswamy Germany 35 999 0.5× 1.2k 0.8× 1.8k 1.6× 652 0.7× 725 1.3× 110 3.7k
Hermann Rogatsch Austria 32 624 0.3× 775 0.5× 573 0.5× 1.1k 1.3× 289 0.5× 80 2.6k
Li‐Yu Lee Taiwan 38 1.7k 0.9× 796 0.5× 1.3k 1.2× 760 0.9× 509 0.9× 134 4.0k

Countries citing papers authored by Robert Stoehr

Since Specialization
Citations

This map shows the geographic impact of Robert Stoehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Stoehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Stoehr more than expected).

Fields of papers citing papers by Robert Stoehr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Stoehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Stoehr. The network helps show where Robert Stoehr may publish in the future.

Co-authorship network of co-authors of Robert Stoehr

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Stoehr. A scholar is included among the top collaborators of Robert Stoehr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Stoehr. Robert Stoehr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agaimy, Abbas, Elan Hahn, Juan C. Hernandez‐Prera, et al.. (2025). Skin-analogue primary poroid neoplasms of the head and neck with YAP1/WWTR1::MAML2/NUTM1 fusions: clinicopathologic and genetic spectrum of a novel tumor family delineated in a series of 10 cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.
2.
Trpkov, Kiril, Inmaculada Ribera‐Cortada, Isabel Trias, et al.. (2025). Renal hemangioblastoma and renal cell carcinoma with fibromyomatous stroma and hemangioblastoma-like areas belong to the spectrum of one entity. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 1 indexed citations
3.
Agaimy, Abbas, Robert Stoehr, Michael Michal, et al.. (2025). Nodular fasciitis: a case series unveiling novel and rare gene fusions, including two cases with aggressive clinical behavior. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 486(6). 1235–1245. 1 indexed citations
4.
Hofman, Paul, Ángel Concha, Anne Cayre, et al.. (2024). Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 484(4). 677–686. 1 indexed citations
5.
Agaimy, Abbas, Atsuko Kasajima, Robert Stoehr, et al.. (2023). Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 482(3). 507–516. 13 indexed citations
6.
7.
Agaimy, Abbas, Raul Perret, Elizabeth G. Demicco, et al.. (2023). GAB1::ABL1 fusions define a distinctive soft tissue neoplasm, with variable perineurial differentiation, and a predilection for children and young adults. Genes Chromosomes and Cancer. 62(8). 449–459. 5 indexed citations
8.
Agaimy, Abbas, Michael Michal, Robert Stoehr, et al.. (2021). Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors. Modern Pathology. 34(8). 1507–1520. 35 indexed citations
9.
Erber, Ramona, Raimund Preidl, Robert Stoehr, et al.. (2021). DICER1-Mutated Botryoid Fibroepithelial Polyp of the Parotid Duct: Report of the First Case. Head and Neck Pathology. 16(2). 573–580. 1 indexed citations
10.
Bertz, Simone, Armin Ensser, Robert Stoehr, et al.. (2020). Variant morphology and random chromosomal integration of BK polyomavirus in posttransplant urothelial carcinomas. Modern Pathology. 33(7). 1433–1442. 9 indexed citations
11.
Weyerer, Veronika, Evgeny A. Moskalev, Florian Haller, et al.. (2019). Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma. Histopathology. 75(6). 865–875. 29 indexed citations
12.
Putte, Elisabeth E. Fransen van de, Judith Bosschieter, Theodorus van der Kwast, et al.. (2018). The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non‐muscle‐invasive bladder cancer. British Journal of Urology. 122(6). 978–985. 23 indexed citations
13.
Wach, Sven, Bernhard Michalke, Verena Lieb, et al.. (2017). Diagnostic potential of major and trace elements in the serum of bladder cancer patients. Journal of Trace Elements in Medicine and Biology. 46. 150–155. 21 indexed citations
14.
Breyer, Johannes, Wolfgang Otto, Ralph M. Wirtz, et al.. (2016). ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ. Urologia Internationalis. 98(3). 282–289. 27 indexed citations
15.
Hartmann, Arndt, Thorsten Schlomm, Simone Bertz, et al.. (2014). Prognostische und prädiktive molekulare Marker urologischer Tumoren. Der Urologe. 53(4). 491–500. 4 indexed citations
16.
Keck, Bastian, Sven Wach, Robert Stoehr, et al.. (2013). Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy. BMC Cancer. 13(1). 71–71. 57 indexed citations
17.
Keck, Bastian, Robert Stoehr, Sven Wach, et al.. (2011). Das plasmazytoide und mikropapilläre Urothelkarzinom. Der Urologe. 50(2). 217–220. 5 indexed citations
18.
Stoehr, Robert, C. Adam, Simone Bertz, et al.. (2006). FGFR3 mutation analysis in flat urothelial hyperplasia - strong evidence for chromosome 9 deletions as the earliest genetic alterations in the development of papillary bladder cancer. Cancer Research. 66. 81–81. 3 indexed citations
19.
Wild, Peter J., Alexander Herr, Christoph Wissmann, et al.. (2005). Gene Expression Profiling of Progressive Papillary Noninvasive Carcinomas of the Urinary Bladder. Clinical Cancer Research. 11(12). 4415–4429. 85 indexed citations
20.
Hartmann, Arndt, Robert Stoehr, Dirk Zaak, et al.. (2004). Early onset bladder cancers show distinct clinical, pathological and molecular features. Cancer Research. 64. 336–336. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shaobo Zhang Breakdown of academic impact, for papers by Fadi Brimo Breakdown of academic impact, for papers by Pantaleo Bufo Breakdown of academic impact, for papers by Akiko Kunita Breakdown of academic impact, for papers by Masatsugu Iwamura Breakdown of academic impact, for papers by Teiichi Motoyama Breakdown of academic impact, for papers by Thomas Papadopoulos Breakdown of academic impact, for papers by Annette Ramaswamy Breakdown of academic impact, for papers by Hermann Rogatsch Breakdown of academic impact, for papers by Li‐Yu Lee
Rankless by CCL
2026